Oral hypoglycemic agents and cardiovascular safety. Relationship with diabetic nephropathy. Rev. Fed. Arg. Cardiol. [Internet]. 2022 Jan. 1 [cited 2026 Oct. 5];46(1):3-9. Available from: https://www.revistafac.org.ar/ojs/index.php/revistafac/article/view/320